Novartis Drug Exjade(R) Recommended by CHMP for EU Approval to Treat

Novartis drug Exjade(R) recommended by CHMP for EU approval to treat

Filed under: drug abuse treatment cost analysis program

Novartis International AG / Novartis drug Exjade® recommended by CHMP for EU approval to treat patients with non-transfusion-dependent thalassemia syndromes . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for …
Read more on Reuters

 

Alcohol is half the problem for substance abusers

Filed under: drug abuse treatment cost analysis program

Alcohol continues to account for nearly half of government-funded substance abuse treatment in Australia. A report from the Australian Institute of Health and Welfare (AIHW) shows 47% of drug treatments carried out between 2010-11 were for problems …
Read more on The Conversation

 

Idaho DUI courts helping change, improve lives

Filed under: drug abuse treatment cost analysis program

"He chose to wake up." Before they are admitted, everyone who applies to DUI court takes a test to determine the level of their addiction and how likely they are to reoffend. … The ignition interlock that tests for alcohol in a client's vehicle costs …
Read more on San Francisco Chronicle

 

Leave a Reply

Your email address will not be published. Required fields are marked *